JNJ Congressional Stock Trades

JOHNSON & JOHNSON

Last disclosed trade Sep 25

Every disclosed trade in JNJ by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice. See every healthcare stock Congress trades.

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Marjorie Taylor Greene · Bought $JNJ · Nov 25 · $1K–$15K

0.73HIGH
Disclosure speedx 0.251.00
Trade sizex 0.250.20
Cluster activityx 0.151.00

3 other members traded this name in the same window.

Track recordx 0.350.80

Coldpine’s read

Greene holds no direct healthcare committee jurisdiction over pharmaceutical firms, making this a general equity purchase rather than a sector-aligned one. The 2-day disclosure lag is fast, meaning the market may not have fully absorbed the filing. Three other members made same-direction JNJ trades within 30 days, indicating cluster activity around the name.

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow $JNJ

Get notified when any member of Congress trades $JNJ. Free, no card, no spam.

Follow free →
131
Disclosed trades
84
Buys
47
Sales
24
Members trading

The record on $JNJ

Coldpine has parsed 131 disclosed trades in $JNJ by 24 members of Congress, drawn from 95 periodic transaction reports dated Dec 6, 2022 through Sep 25, 2026. That is 125 trades from House members and 6 trades from senators, filed 86 by Democrats and 45 by Republicans.

Of the 131 trades with a known filing lag, 6 were reported more than 45 days after the trade date, outside the window the STOCK Act sets. The median lag was 26 days. The longest was 917 days: a $JNJ purchase by Richard Dean McCormick dated Mar 15, 2023, disclosed Sep 17, 2025. How late filing is measured across all of Congress is in the late-filers study.

87 of the 93 trades that list an account holder (94%) were reported under a spouse, dependent child, or joint account rather than the member directly.

Rohit Khanna filed the most $JNJ purchases (46), and Rohit Khanna the most sales (12).

Activity peaked in 2024 with 39 trades. The busiest single month was March 2026, when 5 different members disclosed $JNJ trades. In 6 calendar months out of 40 with activity, three or more members bought $JNJ in the same month, the same-direction overlap Coldpine's cluster detector looks for.

Across the 84 purchases Coldpine can price, $JNJ moved +0.35% on average between the trade date and the disclosure date, against +2.70% for the S&P 500 over the same windows. The stock was higher at disclosure than at the trade in 48% of those purchases. That is a record of what already happened, not a forecast. Method: what stocks do before Congress discloses.

Members who trade JNJ

Recent disclosed trades in JNJ

DateMemberTypeAmount
Sep 25Rohit Khanna(CA)buy$1K–$15K
Sep 8Lloyd Doggett(TX)buy$1K–$15K
Sep 4Rohit Khanna(CA)buy$15K–$50K
Aug 27Thomas H. Kean(NJ)sell$1K–$15K
Aug 20John Boozman(AR)sell$1K–$15K
Aug 7Rohit Khanna(CA)sell$1K–$15K
Jul 30Richard Dean McCormick(GA)sell$1K–$15K
Jul 20Rohit Khanna(CA)buy$1K–$15K
Jun 29Thomas H. Kean(NJ)sell$1K–$15K
Jun 16Rohit Khanna(CA)buy$1K–$15K
Jun 9Lloyd Doggett(TX)buy$1K–$15K
Jun 2Thomas H. Kean(NJ)sell$1K–$15K
Jun 2Rohit Khanna(CA)buy$1K–$15K
Apr 13Rohit Khanna(CA)buy$15K–$50K
Mar 30Alan Armstrong(OK)buy$1K–$15K
Mar 27Alan Armstrong(OK)buy$15K–$50K
Mar 26Thomas H. Kean(NJ)sell$1K–$15K
Mar 19John Boozman(AR)sell$1K–$15K
Mar 19Richard Dean McCormick(GA)sell$1K–$15K
Mar 19Richard Dean McCormick(GA)sell$1K–$15K

Showing 20 of 131 disclosed trades.

Sign up free for the full history, signal scores, the price-vs-trades chart, and Coldpine's read (the AI narrative on each trade).

Create a free account

From Coldpine Research

Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →